Source: United States House of Representatives – Representative Mike Kelly (R-PA)
WASHINGTON, D.C. — Today, U.S. Representatives Mike Kelly (R-PA), Raul Ruiz, M.D. (D-CA), Mariannette Miller-Meeks, M.D. (R-IA), and Gwen Moore (D-WI) introduced the Treat and Reduce Obesity Act (TROA), bipartisan legislation to combat the obesity crisis in the United States by providing regular screenings.
The bill would also prevent diseases associated with obesity through expanded coverage of new health care specialists and chronic weight management medications for Medicare recipients.
“The Treat and Reduce Obesity Act takes a critical step toward improving patient costs and patient outcomes,” said Rep. Kelly. “This bipartisan legislation would allow seniors struggling with obesity to take a responsible, proactive approach to improve their health and live longer, more active lives. I look forward to working with the Trump administration and the team at CMS, including my friend Dr. Mehmet Oz, to make America healthy again!”
“Obesity is a complex, chronic disease and a growing public health crisis that costs our nation billions each year,” said Congressman Dr. Raul Ruiz. “As an emergency physician, I’ve treated countless patients suffering from diabetes, heart disease, and other serious complications linked to obesity. The bipartisan Treat and Reduce Obesity Act would give seniors struggling with obesity access to Medicare coverage for proven medications and behavioral therapies, empowering them to live healthier, longer lives.”
“As a physician and former director of the Iowa Department of Public Health, I have seen firsthand how obesity contributes to serious and preventable health conditions. The Treat and Reduce Obesity Act allows Medicare beneficiaries to access life-changing treatments, including behavioral therapy and FDA-approved medications. This bipartisan legislation improves health outcomes, lowers long-term costs, and helps Americans live longer and healthier lives,” said Dr. Miller-Meeks.
“Obesity poses a growing health risk to millions of Americans, especially older adults. TROA would support critical medical interventions that can help those struggling with obesity, improving the overall health and wellbeing of Medicare beneficiaries,” said Rep. Moore.
You can find the full bill text here.
Senator Bill Cassidy leads companion legislation in the U.S. Senate.
BACKGROUND
According to the Centers for Disease Control and Prevention, diseases associated with obesity such as heart disease, stroke, type II diabetes, and certain types of cancer are the leading causes of preventable death in the U.S. TROA would work to directly prevent these comorbidities.
The scientific understanding of obesity has evolved, recognizing it as a complex, chronic, and relapsing disease. Obesity is a public health crisis in the United States. The total economic and societal impact of obesity rose to $1.4 trillion in the United States in 2018, up from $976 billion in 2014.
A recent study found that Medicare beneficiaries with obesity and at least one other chronic illness could significantly reduce healthcare costs through weight management. Annual savings were estimated at up to 38% or nearly $10,000 in medical cost savings. Additionally, the USC Schaeffer Center found coverage of new obesity treatments could generate approximately $175 billion in cost offsets to Medicare in the first 10 years alone, increasing to $700 billion in 30 years. Coverage of medications to treat obesity will enhance human health and reduce federal healthcare costs by lowering the risks and prevalence of costly obesity-related chronic diseases.
The following organizations have endorsed TROA this Congress: Academy of Nutrition and Dietetics, American Academy of Pas, American Association of Clinical Endocrinologists, American College of Occupational and Environmental Medicine, American Diabetes Association, American Gastroenterological Association, American Medical Group Association, American Psychological Association, American Society for Metabolic & Bariatric Surgery, American Society for Nutrition, Association of Asian Pacific Community Health Organizations, Association of Diabetes Care and Education Specialists, Black Woman’s Health Imperative, Boehringer-Ingelheim, ConscienHealth, Currax, Diabetes Leadership Council, Diabetes Patient Advocacy Coalition, Eli Lilly and Company, Endocrine Society, Gerontological Society of America, Global Liver Institute, Healthcare Leadership Council, HealthyWomen, Intuitive Surgical, MedTech Coalition for Metabolic Health, National Alliance of Healthcare Purchaser Coalitions, National Consumers League, National Council on Aging, National Hispanic Medical Association, National Kidney Foundation, Novo Nordisk, Obesity Action Coalition, Obesity Medicine Association, Ro, Strategies to Overcome and Prevent (STOP) Obesity Alliance, The Obesity Society, Trust for America’s Health, WW Weight Watchers International, and YMCA of the USA.